Clinical Trial Update: AP-003-C Study to Confirm the Efficacy of Ampion™ in Adults With Pain Due to Severe Osteoarthritis of the Knee [Phase 3]

View source ↗

Summary

Phase 3 trial update for Ampion in adults with severe knee osteoarthritis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis
• Knee Pain
• Osteoarthritis of the Knee

Drugs mentioned

• Ampion

Snippet

Sponsor: Ampio Pharmaceuticals. Inc. | Conditions: Osteoarthritis, Knee, Knee Osteoarthritis | Phase 3 | Status: COMPLETED | Results posted: 2022-08-08